Backing a new Major National Audit
Oracle Head & Neck Cancer UK Backs Major Review to Address Growing Crisis in Diagnosis and Treatment
We’re proud to announce that Oracle Head & Neck Cancer UK is backing a major national audit to address the urgent crisis in head and neck cancer care.
With patient numbers increasing by 30% per decade, head and neck cancer remains one of the most common – yet often undetected – cancers. Many patients face late-stage diagnoses, significantly impacting their quality of life.
We’ve donated £40,000 towards this essential two-year review, which aims to identify key areas for improvement in diagnosis, treatment, and outcomes. The Oracle Head & Neck Cancer UK national audit covers the entire United Kingdom, which includes England, Scotland, Wales, and Northern Ireland.
Audit is long overdue
Tamara Kahn, CEO of Oracle Head & Neck Cancer UK, says: “The news about treatment waiting times highlights the need for immediate action. This review will help address the disparities in care across the UK and ultimately improve thousands of lives.”
Professor Vin Paleri, Consultant Head and Neck Surgeon at The Royal Marsden Hospitals, adds: “The lack of a comprehensive national audit for head and neck cancers over the past decade is unacceptable. This process is long overdue and absolutely critical.
“As clinicians, we need this data to drive best practices, reduce treatment disparities, define research strategies and ultimately save lives. Head and neck cancers are uniquely devastating, impacting patients’ ability to speak, eat, and interact socially. We have a responsibility to ensure every patient receives timely, optimal care.”
This comprehensive review will be led by Dr Thomas Cowling, associate professor in health services research and clinical epidemiology at the London School of Hygiene and Tropical Medicine.
Respected organisations support the audit
It is supported by charities and medical specialists including the British Association of Head & Neck Oncology (BAHNO), the British Association of Head & Neck Oncology Nurses (BAHNON), ENT-UK, North West Cancer Research (NWCR), the National Association of Laryngectomee Clubs, Get-A-Head Charity, Restorative Dentistry UK (RD-UK) and the Head & Neck Cancer Coalition, which includes Oracle Head & Neck Cancer UK.
For more information on this vital project and how we’re making a difference in this area please read the article in The Dental Review News.
Oracle is committed to funding pioneering research, supporting patients and their families, and driving change to ensure that no one faces this devastating disease alone. Together with other charities and medical specialists, we’re working to create a better future for those affected.
Coding for a cause: highlights from the Oracle Hackathon
On Friday 6 November, 12 talented students from UCL and the University of Manchester joined us at Pemberton Asset Management‘s London office for the Oracle Hackathon. Working in pairs, they had just one day to build a tool to help with our fundraising activities. Julie Child, our Executive Director, said: “A huge thank you to every…
Julian Gilbert joins Oracle Head & Neck Cancer UK as a trustee
Julian Gilbert, founder of Wealth Matters and a long-standing fundraiser who has had head and Neck Cancer, has joined our board of trustees.
Newsletter October 2026
Julie Child, Executive Director Last week, we held our annual Oncology Meeting in York, attended by 150 clinicians from across the UK. Being able to thank those who support our work was so valuable, and to hear about the progress being made behind the scenes to improve patient outcomes. Our research projects at Oxford, UCL,…
Martyn Dipper shares his cancer story
In September 2021, I was sitting in a car outside a hospital having just been told I had T4 throat cancer. The tumour was too large to operate on. Within weeks I was offered a place on TORPEdO – the first clinical trial in the UK to study Proton Beam Therapy for throat cancer –…
Eating well after head and neck cancer treatment: join our November webinar
A specialist dietitian and a patient talk about food, swallowing and eating out after head and neck cancer treatment.
Thank you to our brilliant Great North Run runners!
This September, two incredible supporters took to the streets of Newcastle for the Great North Run, the world’s largest half marathon, and we couldn’t be prouder of them both. Beth Robinson Scales completed the 13.1-mile route in searing heat, raising over £3,800 for Oracle. Beth ran in honour of her husband Steve, following his recurrence, and…
Bringing the UK’s head and neck oncology community together
The Oracle Head & Neck Cancer UK Oncology Meeting 2026 takes place tomorrow, Friday 25th September, at The Milner Hotel, York. Now in its third year under the Oracle umbrella, this free educational meeting brings together head and neck oncology specialists from around 40 centres across the UK, spanning radiography, nursing, clinical and medical oncology,…
October Webinar: Immunotherapy & Other Developing Treatments
Professor Kevin Harrington explores the latest immunotherapy treatments for head and neck cancer in our upcoming webinar on 6 October.
Mark Hodgson walks 310km in August for Oracle Head and Neck Cancer UK
A Leeds private investigator who was treated for stage 4 cancer of the throat and tongue is walking 10 kilometres every day throughout August for Oracle Head & Neck Cancer UK. He has already passed his original £10,000 target, with 11 days of the challenge still to run. Mark Hodgson is a director of Tremark Associates, a Leeds…
September Webinar: Understanding Head & Neck cancer late effects in survivorship.
From cure to consequence:
Understanding Head & Neck cancer late effects in survivorship.
Thursday 10 September 2026
18:00 – 19:00 pm
Our Late Effects webinar will feature Sabina Khan and Emma Hallam, Macmillan Consultant Radiographers. Both specialise in head and neck post-treatment late effects. They’ll be joined by patient Karen Liesching-Schroder, who will share the patient perspective drawing on her experience of diagnosis, treatment and late effects.
Help Beat Head and Neck Cancer
Oracle Head & Neck Cancer UK is a registered charity in England and Wales (1142037), and in Scotland (SC052790).
Registered as a company limited by guarantee in England and Wales (7125497). Registered address: 167-169, Great Portland Street, 5th Floor, London W1W 5PF.